Results 231 to 240 of about 11,997 (297)

Chiral Au@Ag Core-Shell Nanoparticles for Enantioselective SERS Detection of Bio-Relevant Chiral Molecules. [PDF]

ACS Nanosci Au
Serrano-Freijeiro A, Zarzuela-Amor M, Renero-Lecuna C, Obelleiro-Liz M, Martín VF, Pérez-Juste I, Taboada JM, Casado J, Pastoriza-Santos I, Pérez-Juste J, Bals S, Liz-Marzán LM.   +11 more
europepmc   +1 more source

Thiamidol- A New Depigmenting Agent. [PDF]

Indian Dermatol Online J
Shah T, Kidangazhiathmana A.
europepmc   +1 more source

Mucin-Based Biomimetic Patches for Dynamic Heart Repair: Auxetic Structures and Translational Challenges. [PDF]

Cardiovasc Eng Technol
Gunasegaran R, Al-Ashwal RH, Jusoh N, Ramlee MH, Al-Hazmy SM.   +4 more
europepmc   +1 more source

Design of Poly-Catechol Biodynamers for Potentiation of Antibiotic Efficacy against Drug-Resistant Bacteria. [PDF]

Biomacromolecules
Zeroug-Metz L, Shehu K, Bassil J, Podlecki J, Sonntag P, Koch M, Christoulaki A, Buhler E, Hirsch AKH, Kraegeloh A, Schneider M, Lee S.   +11 more
europepmc   +1 more source

Double Trouble: When Focal and Diffuse Hyperinsulinism Occur Simultaneously.

Horm Res Paediatr
Sanders VR, Lord K, Sigal W, McKnight H, Wilkinson E, Mitteer LM, Boodhansingh KE, Adzick NS, States LJ, Bhatti TR, De Leon DD.   +10 more
europepmc   +1 more source

ENZYMATIC DECARBOXYLATION OF 2,6- AND 2,3-DIHYDROXYPHENYLALANINE [PDF]

Canadian Journal of Biochemistry and Physiology, 1954
The action of dihydroxyphenylalanine (dopa) decarboxylase of guinea pig kidney and of tyrosine decarboxylase of Streptococcus faecalis R on 2,3- and 2,6-dopa has been studied. Compared with 3,4-dopa, these substrates are decarboxylated by the kidney enzyme at rates decreasing in the order: 2,3-, 3,4-, 2,6-dopa.
Theodore L. Sourkes
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Conversion of 3,4-Dihydroxyphenylalanine and Deuterated 3,4-Dihydroxyphenylalanine to Alcoholic Metabolites of Catecholamines in Rat Brain

Journal of Neurochemistry, 1981
Abstract: We have investigated the effects of 3,4‐dihydroxyphenylalanine l‐DOPA) and its deuterated analogue on the concentrations of alcoholic metabolites of catecholamines in rat brain by means of gas chromatography/mass spectrometry with selected‐ion monitoring.
D J Edwards
exaly   +3 more sources

An actinomycete producing L-3,4-dihydroxyphenylalanine from L-tyrosine [PDF]

Journal of Biosciences, 1979
An actinomycete was isolated during a soil screening programme to obtain L-3,4-dihydroxyphenylalanine producers. A mutant of this organism was isolated by chemical mutagenesis and it accumulated 1 g/litre L-dihydroxyphenylalanine when grown on L-tyrosine.
Mahadevan, P. R., Sukumaram, C. P., Singh, D. V., Khedkar, P. D.   +3 more
exaly   +3 more sources

Dihydroxyphenylalanine in Extrapyramidal Disease

JAMA: The Journal of the American Medical Association, 1963
EVIDENCE has been accumulating for the past several years which has implicated dopamine metabolism in the production of extrapyramidal symptoms. Drugs such as reserpine which tend to produce extrapyramidal symptoms as a side effect have been shown to deplete dopamine from the brain.
A J, FRIEDHOFF, L, HEKIMIAN, M, ALPERT, E, TOBACH   +3 more
openaire   +2 more sources